Trending Now
Mustang Bio Inc. (NASDAQ:MBIO) Signs Technology Transfer and GMP Manufacturing Deal...
Mustang Bio Inc. (NASDAQ:MBIO) and Minaris Regenerative Medicine GmBH have entered an agreement for technology transfer and GMP clinical manufacturing of MB-107. MB-107 is...
Akebia Therapeutics Inc (NASDAQ:AKBA) Reports A Drop Of 11.94% In 2020...
Akebia Therapeutics Inc (NASDAQ:AKBA) posted total revenues of $25.37 million (down 11.94% YoY) in 2020 and $56.7 million (down 18.47%) in Q4 2020. Signs a...
Boon Industries (OTCMKTS:BNOW) Ramps Toward Potential Breakout as DiOx+ Gains Traction
The pandemic health crisis has activated investor interest in a number of different market sectors, with chemicals being one of the most...
Popular News
Acadia Pharmaceuticals (NASDAQ:ACAD) Reports NUPLZID® Net Sales Of $120.6 Million In...
Acadia Pharmaceuticals (NASDAQ:ACAD) has announced its Q3 2020 financial results in which net sales were up 27% YoY to $120.6 million. Pimavanserin sales drove Acadia’s...
MAKE IT MODERN
LATEST REVIEWS
Agios Pharmaceuticals Inc. (NASDAQ:AGIO) Posts Net TIBSOVO® Revenue Of $31.7 Million...
Agios Pharmaceuticals Inc. (NASDAQ:AGIO) has announced its Q3 2020 financial results and provided business highlights. Agios posted total revenue of $34.7 million in Q3 In Q3...
MAKE IT MODERN
PERFORMANCE TRAINING
Jaguar Health Inc. (NASDAQ:JAGX) Subsidiary Napo Pharmaceuticals Announces the Filing of New Drug Application
Covid-19 has touched everyone across the globe because if you are not infected, you are affected. People and businesses are becoming helpless and distressed...
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) Finalizes The Enrollment Of 36 Subjects In Ad-RTS-hIL-12 Phase 2...
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) has announced that it completed enrolling 36 patients in its phase 2 clinical trial designed to evaluate a drug combo...
Verastem Inc. (NASDAQ:VSTM) Commences Second Phase VS-6766 Study In KRAS Mutant NSCLC Patients
Verastem Inc. (NASDAQ:VSTM) has announced the commencement of a second phase registration-directed clinical study of VS-6766 in patients with KRAS mutant non-small cell lung...
Vaxart Inc. (NASDAQ:VXRT) Receives FDA Clearance For Oral COVID-19 Vaccine To Commence Phase 1...
Vaxart Inc. (NASDAQ:VXRT) is moving closer to having clinical data for its oral COVID-19 vaccine candidate after it announced that the FDA had cleared...
Atara Biotherapeutics Inc. (NASDAQ:ATRA) Presents Positive ATA188 Study Data Showing Safety and Sustained Disability...
Atara Biotherapeutics Inc. (NASDAQ:ATRA) has announced the release of efficacy and safety data of its First Phase ATA 188 study in progressive forms of...
MAKE IT MODERN
[/tdc_zone]